165 related articles for article (PubMed ID: 15142463)
1. [CD4+CD25+T regulatory cells in peripheral blood of B-NHL patients with or without chemotherapy].
Shi YX; Zhang XS; Liu DG; Li YQ; Guan ZZ; Jiang WQ
Ai Zheng; 2004 May; 23(5):597-601. PubMed ID: 15142463
[TBL] [Abstract][Full Text] [Related]
2. [CD4+ CD25high regulatory T cells in peripheral blood of patients with B cell non-Hodgkin's lymphoma].
Liu L; Yao JX; Ding Q; Huang SA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):119-22. PubMed ID: 16584606
[TBL] [Abstract][Full Text] [Related]
3. [Distribution of CD8+CD28- T cells and CD3+CD56+ NKT cells in peripheral blood of patients with B-cell non-Hodgkin's lymphoma].
Shi YX; Zhang XS; Liu DG; Guan ZZ; Jiang WQ
Ai Zheng; 2004 Nov; 23(11 Suppl):1437-42. PubMed ID: 15566652
[TBL] [Abstract][Full Text] [Related]
4. Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
Gergely L; Aleksza M; Váróczy L; Ponyi A; Sipka S; Illés A; Szegedi G
Eur J Haematol; 2004 May; 72(5):336-41. PubMed ID: 15059068
[TBL] [Abstract][Full Text] [Related]
5. [Perioperative changes of cellular immune response of patients with esophageal carcinoma evaluated through detecting AgNOR content in peripheral blood T lymphocytes and T cell subsets].
Wang JY; Dai SQ; Ye WF; Long H; Lin P; Li BJ; Rong TH
Ai Zheng; 2005 Jul; 24(7):861-4. PubMed ID: 16004816
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of T cell subsets in peripheral blood of B cell non-Hodgkin's lymphoma patients.
Dehghani M; Sharifpour S; Amirghofran Z; Zare HR
Med Oncol; 2012 Dec; 29(4):2364-71. PubMed ID: 22307765
[TBL] [Abstract][Full Text] [Related]
7. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
[TBL] [Abstract][Full Text] [Related]
8. Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma.
Scheid C; Pettengell R; Ghielmini M; Radford JA; Morgenstern GR; Stern PL; Crowther D
Bone Marrow Transplant; 1995 Jun; 15(6):901-6. PubMed ID: 7581089
[TBL] [Abstract][Full Text] [Related]
9. Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma.
Fozza C; Corda G; Virdis P; Contini S; Barraqueddu F; Galleu A; Isoni A; Cossu A; Dore F; Careddu MG; Bonfigli S; Giannico B; Longinotti M
Eur J Haematol; 2015 Apr; 94(4):298-309. PubMed ID: 25040028
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients].
Zhang HH; Guo F; Fei R; Ma H; Cong X; Wei L; Chen HS
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):511-5. PubMed ID: 18649763
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
Martelli M; Vignetti M; Zinzani PL; Gherlinzoni F; Meloni G; Fiacchini M; De Sanctis V; Papa G; Martelli MF; Calabresi F; Tura S; Mandelli F
J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768
[TBL] [Abstract][Full Text] [Related]
12. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
13. Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.
Ansell SM; Stenson M; Habermann TM; Jelinek DF; Witzig TE
J Clin Oncol; 2001 Feb; 19(3):720-6. PubMed ID: 11157023
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].
Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ
Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560
[TBL] [Abstract][Full Text] [Related]
15. Detection and Significance of CD4+CD25+CD127dim Regulatory T Cells in Individuals with Severe Aplastic Anemia.
Qi W; Ren Y; Fu R; Wang H; Liu C; Shao Z
Turk J Haematol; 2015 Sep; 32(3):220-7. PubMed ID: 25912955
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma.
Dang NH; Hagemeister FB; Pro B; McLaughlin P; Romaguera JE; Jones D; Samuels B; Samaniego F; Younes A; Wang M; Goy A; Rodriguez MA; Walker PL; Arredondo Y; Tong AT; Fayad L
J Clin Oncol; 2004 Oct; 22(20):4095-102. PubMed ID: 15353540
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of bronchoalveolar lavage fluid in patients with B-cell lymphoma before and after COP-BLAM therapy].
Arai N; Shirai T
Rinsho Ketsueki; 1993 Jun; 34(6):705-11. PubMed ID: 7690074
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma.
Yang ZZ; Novak AJ; Stenson MJ; Witzig TE; Ansell SM
Blood; 2006 May; 107(9):3639-46. PubMed ID: 16403912
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
20. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response.
Levine AM; Tulpule A; Espina B; Sherrod A; Boswell WD; Lieberman RD; Nathwani BN; Welles L
J Clin Oncol; 2004 Jul; 22(13):2662-70. PubMed ID: 15226333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
